We're not doing 30 bets a year': Vijay Pande on betting small after running $4B at a16z
This story is from 2026-08-29. It is preserved in the archive; the latest stories are on the live feed.
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared da…
Read the full story at TechCrunch AI ↗
Timeline · 1 report
- 2026-08-29 17:36 · TechCrunch AI
We're not doing 30 bets a year': Vijay Pande on betting small after running $4B at a16z